|
12th Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
NCCIH, NCI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR
|
2014
|
|
|
2024-2028 NIH-Wide Strategic Plan on Research on the Health of Women
|
Other
|
AHRQ, CDC, FDA, HRSA, OASH
|
CC, CSR, NCATS, NCCIH, FIC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ OEPR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ SGMRO
|
2022
|
|
|
3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|